RESUMO
CCR-5 is a major cellular coreceptor for R5 strains of HIV-1. Individuals carrying a homozygous 32-base-pair deletion in this gene are apparently healthy and are relatively resistant to HIV-1 infection. Since CCR5 appears to be dispensable for the host, but important for initial HIV-1 infection, CCR5 mRNA is an excellent therapeutic target for inhibiting HIV-1 replication via ribozyme knockout. We report here that hairpin ribozymes are able to reduce cellular CCR5 mRNA and cell surface CCR5 when stably introduced into PM1 cells by transduction with recombinant adenoassociated viral vector. The ribozymes effectively protect the cells from infection by R5 HIV-1 strains or non-syncytium-inducing clinical isolates commensurate with a reduction in CCR5 mRNA. These results suggest a novel gene therapy approach to preventing or slowing the disease progression of HIV-1 infection.
Assuntos
Antagonistas dos Receptores CCR5 , Terapia Genética , HIV-1/efeitos dos fármacos , RNA Catalítico/genética , Linhagem Celular , HIV-1/metabolismo , Humanos , Cinética , Fusão de Membrana/efeitos dos fármacos , Conformação de Ácido Nucleico , RNA Catalítico/química , RNA Catalítico/farmacologia , RNA Mensageiro/antagonistas & inibidores , RNA Mensageiro/metabolismo , Receptores CCR5/genética , Receptores CCR5/metabolismoRESUMO
Recombinant adenoassociated virus (rAAV) type 2 vectors have been used to transduce a wide variety of cell types, including hematopoietic progenitor cells. For in vivo gene transfer, it is desirable to have an rAAV vector that specifically transduces selected target cells. As a first step toward generating an rAAV vector capable of targeting delivery in vivo, we have engineered a chimeric protein combining the AAV capsid protein and the variable region of a single-chain antibody against human CD34 molecules, a cell surface marker for hematopoietic stem/progenitor cells. Inclusion of the chimeric CD34 single-chain antibody-AAV capsid proteins within an rAAV virion significantly increased the preferential infectivity of rAAV for the CD34+ human myoleukemia cell line KG-1, which is normally refractory to rAAV transduction. Antibodies against the single-chain antibody and the CD34 protein blocked this transduction. This chimeric vector represents a significant improvement in the host range of rAAV and the first step toward specific gene delivery by rAAV vectors to cells of choice, in this case, hematopoietic progenitor cells, for the treatment of human disease.
Assuntos
Antígenos CD34 , Dependovirus/genética , Marcação de Genes/métodos , Vetores Genéticos/genética , Região Variável de Imunoglobulina/genética , Anticorpos Anti-Idiotípicos , Anticorpos Bloqueadores , Anticorpos Monoclonais , Antígenos CD34/imunologia , Antígenos CD34/metabolismo , Ligação Competitiva , Biomarcadores , Capsídeo/genética , Clonagem Molecular , Dependovirus/isolamento & purificação , Terapia Genética/métodos , Células HeLa , Células-Tronco Hematopoéticas , Humanos , Leucemia Mieloide Aguda , RNA Mensageiro/biossíntese , RNA Viral/biossíntese , Proteínas Recombinantes de Fusão , Células Tumorais Cultivadas , Proteínas Virais/biossíntese , VírionRESUMO
The human immunodeficiency virus type 1 strain MN (HIV-1MN) principal neutralizing determinant (PND, V3 loop) was introduced into infectious molecular clones HIV-2KR and simian immunodeficiency virus mm239 (SIVmm239) by hybridization PCR, replacing the corresponding HIV-2 or SIV envelope cysteine loops with the HIV-1 coding sequence. The HIV-2 chimera (HIV-2KR-MNV3) was found to be capable of infecting a number of T-cell lymphoblastic cell lines as well as primary peripheral blood mononuclear cells. In contrast, the SIV chimera (SIV239MNV3) was not replication competent. Envelope produced by HIV-2KR-MNV3 but not the parental HIV-2KR was recognized by V3-specific and HIV-1-specific polyclonal antisera in radioimmunoprecipitation assays. HIV-2-specific antisera recognized both the chimeric and parental virus but not HIV-1MN. The chimeric HIV-2KR-MNV3 virus proved to be exquisitely susceptible to neutralization by HIV-1-specific and V3-specific antisera, suggesting the potential for use in animal models designed to test HIV-1 vaccine candidates which target the PND.
Assuntos
Produtos do Gene env/biossíntese , Produtos do Gene env/imunologia , HIV-1/fisiologia , HIV-2/fisiologia , Linfócitos T/virologia , Replicação Viral , Sequência de Bases , Linhagem Celular , Quimera , Cisteína , Primers do DNA , Produtos do Gene env/genética , HIV-1/genética , HIV-2/genética , HIV-2/patogenicidade , Humanos , Cinética , Dados de Sequência Molecular , Mutagênese , Reação em Cadeia da Polimerase , Ensaio de Radioimunoprecipitação/métodos , Vírus da Imunodeficiência Símia/fisiologia , Linfócitos T/imunologia , Células Tumorais CultivadasRESUMO
One of the principal problems with using recombinant adeno-associated virus vectors (rAAV) as vehicles for gene delivery has been the difficulty in obtaining high-titer virus stocks after the initial transfection into producer cells. In this report we describe a method for transfecting cells at extremely high efficiency with rAAV vector DNA and complementation plasmid while simultaneously infecting those cells with replication competent adenovirus using adenovirus-polylysine-DNA complexes. We further show that this technique results in an increase in rAAV transducing titer by two orders of magnitude over what is typically achieved by standard calcium phosphate transfection.
Assuntos
Adenoviridae/genética , Dependovirus/genética , Vetores Genéticos , HIV-1/genética , RNA Catalítico/biossíntese , Transfecção/métodos , Adenoviridae/fisiologia , DNA Viral/administração & dosagem , DNA Viral/metabolismo , Portadores de Fármacos , Teste de Complementação Genética , Células HeLa , Humanos , Plasmídeos , Polilisina/administração & dosagem , RNA Catalítico/genética , Recombinação Genética , Replicação ViralRESUMO
CHO-K1 cells, wild type (WT), grow in a defined medium with insulin as the only essential hormone. When starved for insulin, these cells accumulate in G0/G1 stage. Insulin binding to its receptor stimulates DNA synthesis and cell division and induces an increase in abundance of mRNA for c-fos, c-jun, Krox-20, Krox-24 (zif/268), fra-1, jun-B, c-myc, and JE. The kinetics of induction of these genes are similar to that shown with serum induction of 3T3. These genes show maximum stimulation at insulin concentrations of 20, 160, or 320 ng/ml and their expression is inhibited at higher concentrations. The addition of cycloheximide results in superinduction. The WT and insulin-independent mutants show no detectable signal for KC, fos-b, or nur77 and no increase over the basal level of pI-15, probably eliminating these genes as participants in the insulin mitogenic signal. These mutants synthesize DNA in the absence of insulin at rates that vary from 4 to 12 times that of the quiescent (insulin unstimulated) WT and are further inducible by insulin. The mutants have "constitutive" levels of Krox-24 (zif/268), fra-1, jun-B, c-myc, and JE (INS-type 2 genes) mRNAs that vary from mutant to mutant, reaching a maximum of an 8-fold increase for fra-1 and JE over the quiescent WT levels. There were no detectable levels of mRNA for genes c-fos and Krox-20 and no increase in level of mRNA for c-jun (INS-type 1 genes) as compared to the quiescent WT. Thus, although these INS-type 1 and type 2 genes may be involved in the full insulin mitogenic signal, the constitutive up-regulation of only genes in INS-type 2 is sufficient for insulin-independent DNA synthesis and cell division. Analysis of hybrids constructed between WT and mutant 27 indicate that the mutant phenotype is recessive, pointing to the existence of a regulatory gene producing a negative regulator.
Assuntos
Ciclo Celular , Insulina/fisiologia , Receptor de Insulina/fisiologia , Animais , Northern Blotting , Linhagem Celular , Quimiocina CCL2 , Fatores Quimiotáticos/genética , Cricetinae , Cricetulus , Cicloeximida/farmacologia , DNA/biossíntese , Proteínas de Ligação a DNA/genética , Feminino , Expressão Gênica/efeitos dos fármacos , Genes Recessivos , Ovário , Proteínas Proto-Oncogênicas/genética , Proteínas Proto-Oncogênicas c-fos , Proteínas Proto-Oncogênicas c-jun , Proteínas Proto-Oncogênicas c-myc/genética , RNA Mensageiro/genética , Fatores de Transcrição/genéticaRESUMO
Insulin is the only hormone required for continued growth of Chinese hamster ovary CHO-K1 cells in the defined medium M-F12. When CHO-K1 cells are incubated in M-F12 without insulin for 48-72 hr, the cells accumulate in G1. In response to physiological concentrations of insulin an 18-fold increase in rate of DNA synthesis occurs due to cells entering S phase after an 8- to 10-hr lag; cell division begins after 24 hr. The inhibitory effect of actinomycin D and 5,6-dichlorobenzimidazole riboside indicates that RNA synthesis is required for progression to S phase. CHO-K1 cells possess insulin receptors, and the insulin effect results from insulin binding to its own receptor: (i) Binding occurs at physiological insulin concentrations with a half-maximal stimulation at approximately 14 ng/ml. (ii) At insulin concentrations used, insulin-like growth factor I and II (IGF-I and IGF-II) have little or no effect. (iii) Scatchard analysis of 125I-labeled insulin binding shows the curvilinear response typical of insulin. (iv) The Kd for the so-called high-affinity binding site and the Ke are characteristic of the insulin receptor. (v) At the minimal insulin concentrations that stimulate growth, IGF-I and IGF-II compete poorly with insulin for insulin binding, insulin competes poorly with IGF-I for IGF-I binding, and affinity labeling with 125I-labeled insulin identifies a polypeptide (Mr = 125,000) typical of the alpha subunit of the insulin receptor.
Assuntos
Ciclo Celular/efeitos dos fármacos , Replicação do DNA/efeitos dos fármacos , Insulina/farmacologia , Receptor de Insulina/fisiologia , Animais , Ligação Competitiva , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Cricetinae , Cricetulus , Dactinomicina/farmacologia , Feminino , Insulina/metabolismo , Interfase/efeitos dos fármacos , Cinética , Mitógenos , Ovário , Somatomedinas/farmacologiaRESUMO
Insulin, FeSO4, or transferrin are major requirements together with HEPES buffer and selenium for the growth of CHO-K1 (CCL 61) in a modified F12 medium (M-F12). Insulin stimulates growth at 1 ng/ml to 10 micrograms/ml. In the defined medium minus insulin, CHO-K1 grows slowly as elongated, elliptical cells in parallel arrays typical of normal diploid fibroblasts in contrast to round-to-cuboid cells in loosely overlapping arrays in the presence of serum or insulin. During prolonged incubation in the absence of insulin the cells gather up into a large spherical cluster of viable cells. Insulin "independent" mutants have been isolated whose growth rate during exponential phase in the absence of insulin (48 h to 84 or 96 hrs) is 2.7 to 3.6 times that of the parental culture. Insulin stimulates the growth of these variants only during the first 48 h and is inhibitory at 50 to 500 ng/ml during the exponential phase. Insulin induction of the A system of amino acid transport occurs in about 8 h and requires both protein and RNA synthesis.